Market Cap
$219.31B
$132.58B
Country
United Kingdom
United States
Employees
89.90K
88.00K
Industry
🇬🇧 United Kingdom
🇺🇸 United States
Outstanding Shares
3.11B
5.69B
Comparison Verdict
About AstraZeneca and Pfizer
AstraZeneca (AZN) and Pfizer (PFE) are both prominent companies in their respective sectors. This comparison helps investors understand the key differences between these two stocks.
Key Takeaways
- Market Cap: AstraZeneca ($219.31B) vs Pfizer ($132.58B)
- Valuation: AstraZeneca has a P/E ratio of $28.11 vs $16.76 for Pfizer
- Dividend Yield: AstraZeneca offers 2.20% vs 7.30% from Pfizer
- Assets: AstraZeneca has $104.03B in total assets compared to $213.40B for Pfizer
- 1-Year Performance: AstraZeneca gained 0.70% vs gain of 0.23% for Pfizer
- Outstanding Shares: AstraZeneca has 3.11B shares vs 5.69B for Pfizer